Yuying Zhang: Grateful to Present on CD44 as A Potential Plasma-Independent Alternative to IVIG in ITP
Yuying Zhang, Laboratory Medicine and Pathobiology PhD Candidate at University of Toronto, shared on LinkedIn:
”I am very grateful to have given my first conference oral presentation at the 2026 Canadian Society for Transfusion Medicine Annual Conference in Hamilton.
I presented one of my PhD research project on targeting human CD44 as a potential plasma-independent alternative to IVIg in immune thrombocytopenia.
This was a meaningful milestone for me as my first oral presentation at a conference.
I really appreciated the opportunity to share my work, receive thoughtful questions, and connect with the transfusion medicine community.
A huge thank you to my supervisor Dr. Alan H. Lazarus, my mentor Alequis Pavon Oro, my supportive lab members, the vivarium staff, the research core facilities at the Keenan Research Centre for Biomedical Science and my thesis advisory committee members.
I am also grateful to Canadian Blood Services, Mitacs, the UofT Department of Laboratory Medicine & Pathobiology for their support.
Excited to keep learning, improving, and moving forward.”
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 16:53Leonardo Roever: Can a Simple Cholesterol Ratio Predict Post-Stroke Depression?
-
Jun 6, 2026, 16:21Abdulkader Jamal Eddin: ABO Blood Group, COVID-19 and Early Respiratory Outcomes in Acute PE
-
Jun 6, 2026, 15:16Don Deyo: Breakthrough Therapy for Post-Stroke Upper Limb Impairment Now Published
-
Jun 6, 2026, 15:14Julianne Chong: Components of Antithrombotic Stewardship Programs from an International Perspective
-
Jun 6, 2026, 15:13Vincent Ten Cate: The Largest Blood-Based EWAS of Atherosclerosis to Date
-
Jun 6, 2026, 14:58Pearla Awad: Liposomal Iron Is Better Tolerated, With Fewer Adverse Effects and Lower Constipation Rates
-
Jun 6, 2026, 14:48Eliminating DOAC Interference in Routine Coagulation Assays – JTH
-
Jun 6, 2026, 14:35Sophie Davies: Patients Often Don’t Consider Supplements to Be ‘Medications’
-
Jun 6, 2026, 14:30Alan Nurden: Honoring the Legacy of Dr. Richard Aster